In addition to LGMN, sialic acid binding Ig like lectin 9 (SIGLEC9), which is expressed in a unique immunosuppressive macrophage subpopulation from GBM patients who do not respond to anti-PD-1 treatment, has been identified. This evidence concerns the gene SIGLEC9 and glioblastoma.